Home > Income Statement > VENUS REMEDIES

VENUS REMEDIES
Consolidated Net Profit

    Back to Income Statement
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹28 Cr₹27 Cr₹41 Cr₹62 Cr₹-10.00 Cr

What is the latest Consolidated Net Profit of VENUS REMEDIES ?

The latest Consolidated Net Profit ratio of VENUS REMEDIES is ₹28 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹28 Cr
Mar2023₹27 Cr
Mar2022₹41 Cr
Mar2021₹62 Cr
Mar2020₹-10.00 Cr

How is Consolidated Net Profit of VENUS REMEDIES Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹28 Cr
7.25
Mar2023 ₹27 Cr
-34.77
Mar2022 ₹41 Cr
-34.07
Mar2021 ₹62 Cr
Positive
Mar2020 ₹-10.00 Cr -

Compare Consolidated Net Profit of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹482.5 Cr 24.5% 21.8% -9.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,764.0 Cr 0.6% -2.1% 16.5% Stock Analytics
DIVIS LABORATORIES ₹163,010.0 Cr 4.3% 6.5% 63.9% Stock Analytics
CIPLA ₹118,905.0 Cr 3.6% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,523.0 Cr 3% -8.4% 0% Stock Analytics
ZYDUS LIFESCIENCES ₹100,015.0 Cr 3.2% -1% 27.4% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

24.5%

21.8%

-9.1%

SENSEX

0.5%

0.3%

7.9%


You may also like the below Video Courses